LRRC25 Antikörper (PE)
Kurzübersicht für LRRC25 Antikörper (PE) (ABIN1712679)
Target
Alle LRRC25 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human LRRC25
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM: 1:20-100
Optimal working dilution should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- LRRC25 (Leucine Rich Repeat Containing 25 (LRRC25))
-
Andere Bezeichnung
- Lrrc25
-
Hintergrund
-
Synonyms: MAPA, Leucine-rich repeat-containing protein 25, Monocyte and plasmacytoid-activated protein, LRRC25, UNQ6169/PRO20174
Background: May be involved in the activation of cells of innate and acquired immunity.
-
Gen-ID
- 126364
-
UniProt
- Q8N386
Target
-